Venezuelan President Nicolás Maduro said on Sunday that his country would publish “in the coming days” studies on the drug Carvativir, which, according to the president himself, acts in a complementary way in treatments against SARS-VOC -2 virus, which causes covid-19 .
“A brutal campaign has been launched against Carvativir, it is an antiviral, it helps the antiviral to stop, to neutralize the coronavirus cell,” Maduro said during his weekly assessment of the fight against covid-19 in Venezuela.
“It is scientifically proven, we have the study (and) in the coming days, the international scientific publication will be executed with all Carvativir studies,” he added.
PAHO REQUESTED THE PUBLICATION OF THE STUDIES
Last Wednesday, the Pan American Health Organization (PAHO) requested the publication of findings on Carvativir, a drug developed in Venezuela that Maduro had defended days before as “miracle drops” that neutralize the coronavirus 100%.
However, Maduro corrected his initial statements, which he acknowledged had caused “extraordinary controversy” and later noted that Carvativir was “complementary” to treatments for covid-19.
Today, the president said the drug’s high doubts were based on the “envy” and “selfishness” of world powers and big pharmaceutical companies.
“(Because of) the dirtiness of the minds of some, the reason for science seems to struggle with ideological and political criteria,” he added.
“ENCOURAGING” RESULTS
Venezuelan Science Minister Gabriela Jiménez – who accompanied Maduro today – said a Venezuelan scientific research institute conducted the first studies on the drug, which were completed in two private laboratories abroad.
The results (studies) showed that patients had a modulating effect with Carvativir, Jiménez said. “The results are encouraging and the articles are already available,” he added.
MASS PRODUCTION OF MEDICINES
Last week, Maduro indicated that his government would immediately begin “mass production” of the drug, for which it intends to establish a direct distribution system to ensure that doses arrive at all hospitals and health centers in general.
In addition, he said that he estimates the export of thousands of doses of Carvativir to the countries that together with Venezuela are part of the ALBA-TCP bloc (Cuba, Nicaragua, Bolivia, Haiti and other Caribbean nations) and its trade with other nations with which maintains a “strategic relationship”, although he did not mention any.
In this regard, the Secretary General of ALBA-TCP, Sacha Llorenti, said in an interview broadcast on Venezuelan public television on Sunday that Carvativir is “a sign of hope” in the fight against covid-19 in the region., And that he hopes will be produced in a massive way.